Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00010
|
|||||
| EM Name |
Citrate
|
|||||
| Synonyms |
citric acid; 2-hydroxypropane-1,2,3-tricarboxylic acid; Citric acid, anhydrous; Citro; citrate; Citretten; Anhydrous citric acid; Aciletten; Chemfill; Hydrocerol A; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-; Kyselina citronova; 2-hydroxy-1,2,3-propanetricarboxylic acid; 2-Hydroxytricarballylic acid; Citric acid anhydrous; Caswell No. 221C; F 0001 (polycarboxylic acid); 3-Carboxy-3-hydroxypentane-1,5-dioic acid; 2-Hydroxypropanetricarboxylic acid; beta-Hydroxytricarballylic acid; FEMA Number 2306; K-Lyte
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=311"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H8O7
|
|||||
| Canonical SMILES |
C(C(=O)O)C(CC(=O)O)(C(=O)O)O
|
|||||
| InChI |
InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
|
|||||
| InChIKey |
KRKNYBCHXYNGOX-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 77-92-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 192.12 | Topological Polar Surface Area | 132 | ||
| Heavy Atom Count | 13 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:30769
|
|||||
| DT(s) "handling" This EM | GC1 | Transporter Info | Mitochondrial glutamate carrier 1 | [1] | ||
| NaCT | Transporter Info | Sodium-coupled citrate transporter | [2] | |||
| OAT3 | Transporter Info | Organic anion transporter 3 | [3] | |||
| SLC25A1 | Transporter Info | Tricarboxylate transport protein | [4] | |||
| SLC26A6 | Transporter Info | Anion exchange transporter | [5] | |||
| References | ||||||
| 1 | LC-MS-based metabolomics revealed SLC25A22 as an essential regulator of aspartate-derived amino acids and polyamines in KRAS-mutant colorectal cancer. Oncotarget. 2017 Sep 20;8(60):101333-101344. | |||||
| 2 | Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy. Molecules. 2017 Feb 28;22(3). | |||||
| 3 | Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos. 2013 Oct;41(10):1825-34. | |||||
| 4 | Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome. J Biol Chem. 2015 Sep 18;290(38):23240-53. | |||||
| 5 | Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res. 2012 Sep 7;11(9):4425-35. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.